Pediatrix Medical Group, Inc. - Common Stock (MD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MD on NYSE
CUSIP
58502B106
Type / Class
Equity / Common Stock
Shares outstanding
85.7M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
80.6M
Holdings value
$1.35B
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
265
Number of buys
136
Number of sells
-126
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pediatrix Medical Group, Inc. - Common Stock (MD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14.6% $180M 12.5M BlackRock, Inc. Jun 30, 2025
Rubric Capital Management LP 3.67% $38.9M 3.15M Rubric Capital Management LP Dec 31, 2024
ALLIANCEBERNSTEIN L.P. 2.2% -72.5% $27.8M -$71M 1.93M -71.9% AllianceBernstein L.P. May 31, 2025

Institutional Holders of Pediatrix Medical Group, Inc. - Common Stock (MD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 80.6M $1.35B -$2.05M $16.75 265
2025 Q2 80.7M $1.16B +$486K $14.35 264
2025 Q1 80.2M $1.16B -$29.4M $14.49 239
2024 Q4 82.3M $1.08B -$30M $13.12 227
2024 Q3 85.7M $993M -$10.7M $11.59 215
2024 Q2 87.4M $659M -$5.81M $7.55 223
2024 Q1 84.2M $844M +$26.7M $10.03 208
2023 Q4 82.1M $764M +$508K $9.30 218
2023 Q3 81.3M $1.03B -$12.6M $12.71 196
2023 Q2 81.4M $1.16B -$24.3M $14.21 207
2023 Q1 83.7M $1.25B -$7.78M $14.91 205
2022 Q4 84.3M $1.25B +$1.16M $14.86 200
2022 Q3 84.2M $1.39B -$43.4M $16.51 194
2022 Q2 86.4M $1.82B +$47.1M $21.01 187
2022 Q1 84.4M $1.98B +$15.7M $23.48 205
2021 Q4 83.7M $2.28B -$11M $27.21 196
2021 Q3 84M $2.39B -$125M $28.43 212
2021 Q2 88.4M $2.67B -$63.2M $30.15 214
2021 Q1 90.8M $2.31B -$23.2M $25.47 204
2020 Q4 91.9M $2.26B +$105M $24.54 194
2020 Q3 83.4M $1.36B -$40.1M $16.28 198
2020 Q2 85.7M $1.47B +$61.3M $17.10 200
2020 Q1 83.2M $969M -$26.9M $11.64 209
2019 Q4 78.5M $2.18B -$2.74M $27.79 252
2019 Q3 78.8M $1.78B -$7.09M $22.62 220
2019 Q2 79.1M $1.99B -$502K $25.23 240
2019 Q1 78.9M $2.14B -$119M $27.17 279
2018 Q4 82.3M $2.72B -$258M $33.00 293
2018 Q3 88.7M $4.14B -$32.2M $46.66 314
2018 Q2 90.2M $3.9B -$118M $43.28 315
2018 Q1 92M $5.12B -$86.6M $55.63 340
2017 Q4 93.6M $5B +$96.9M $53.44 324
2017 Q3 92.8M $4B -$196M $43.12 331
2017 Q2 94.8M $5.72B -$372M $60.37 329
2017 Q1 100M $6.95B +$634M $69.38 358
2016 Q4 98.8M $6.58B +$97.7M $66.66 384
2016 Q3 94.8M $6.28B +$164M $66.25 380
2016 Q2 92.3M $6.68B +$98.7M $72.43 387
2016 Q1 88.5M $5.72B -$11.2M $64.62 374
2015 Q4 95.5M $6.85B +$278M $71.66 396
2015 Q3 91M $6.99B -$725M $76.79 374
2015 Q2 97.2M $7.2B +$133M $74.11 356
2015 Q1 95M $6.89B -$165M $72.51 351
2014 Q4 97.5M $6.44B -$154M $66.11 332
2014 Q3 99.3M $5.45B +$36.5M $54.82 325
2014 Q2 98.7M $5.74B -$94.4M $58.15 332
2014 Q1 100M $6.23B -$133M $61.98 318